— ONC-783 is the first-and-only clinical-stage T-cell engager targeting a cancer-specific glycoform of CD24 (neoCD24) ...
First DLC due out before the end of the year. Pearl Abyss has detailed its plans for smash hit action role-playing game ...
Envision Energy, a global leader in green technology, today announced a collaboration with Sasol, a global energy and ch...
A federal appeals court signaled that it might not allow a lawsuit brought by fishing industry businesses and trade grou...
The EPF reform is more than a payroll change. It gives employers an opportunity to redesign retirement benefits by combi...
Partnership matters and family blessings will shape the day's mood. Unexpected messages and proposals may arrive, influe...
New research highlights how stablecoins and unified multi-rail settlement infrastructure bridge the gap between Africa's...
DJI's First Dual-Lens Gimbal Camera Unlocks Cinematic Potential with 17 Stops of Dynamic Range and All-New 10-bit D-Log ...
NIFTY continues to consolidate within the zone of a potential bearish breakout, with price still ranging around a key re...
With the aid of AI, scientists have identified a potential new antibiotic to treat gonorrhea, a sexually transmitted bac...